Nano-X Imaging Ltd.
NASDAQ:NNOXMedical - Devices
-$0.03 today
- Market cap
- $50.94M
- Beta
- 1.17
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$1.12
Volume 0.52M
Average 1.46M
NNOX Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Nano-X Imaging Ltd.NASDAQ: NNOX
Net Receivables · Q4 FY2025 · quarter ended Dec 2025
Net receivables rises 11.5% from a year ago
Net receivables stood at $2.01M at the end of Q4 FY2025, up 11.5% from a year earlier and up 3.9% from the prior quarter. Over 3 fiscal years it compounded at +27.2% a year.
Context
- Net receivables amounted to 1.2% of total assets at the end of Q4 FY2025, up 0.4 pp from a year earlier.
- Net receivables increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether net receivables keeps rising in the next quarterly balance sheet after a +11.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 2.01M USD
- Year-over-year change
- +11.5%
- 4-year CAGR
- +17.6%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.01M | +11.5% |
| FY2024 | 2024-12-31 | 1.81M | +21.6% |
| FY2023 | 2023-12-31 | 1.48M | +51.9% |
| FY2022 | 2022-12-31 | 977K | -7.0% |
| FY2021 | 2021-12-31 | 1.05M | — |
Net Receivables vs competitors
How NNOX compares with its peers on the latest reported figures
- NNOX's Dec 2025 net receivables of $2.01M is the 9th highest of the 11 companies compared; the peer median is $7.73M.
- Its year-over-year change of +11.5% is the 4th highest of 11, against a peer median of -6.4%.
- Net receivables amounts to 1.2% of total assets for NNOX, versus a peer median of 8.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $59.15M | -7.7% | +7.2% | 14.3% | |
| Mar 2026 | $41.87M | +14.3% | -15.5% | 14.6% | |
| Mar 2026 | $26.78M | -5.2% | +16.4% | 7.3% | |
| Mar 2026 | $25.32M | -31.4% | +0.3% | 10.2% | |
| Mar 2026 | $9.45M | +58.5% | +15.8% | 12.8% | |
| Mar 2026 | $6M | +55.2% | +10.4% | 16.2% | |
| Mar 2026 | $5.22M | -4.4% | +61.5% | 7.3% | |
| Mar 2026 | $4.25M | -23.1% | -32.1% | 2.2% | |
| Dec 2025 | $2.01M | +11.5% | +27.2% | 1.2% | |
| Mar 2026 | $58K | -25.6% | -83.6% | 0.0% | |
| Mar 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding NNOX) | $7.73M | -6.4% | +7.2% | 8.7% | |
Competitors are the stored peer set for NNOX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 66.65M | 38.46M | 56.38M | 39.3M | 49.15M |
| Short-term Investments | 22.07M | 39.16M | 26.01M | 33.9M | 10.46M |
| Net Receivables | 1.05M | 977K | 1.48M | 1.81M | 2.01M |
| Inventory | 3.13M | 2.41M | 2.36M | 1.49M | 3.07M |
| Other Current Assets | 1.97M | 1.45M | 1.14M | 1.35M | 2.1M |
| Total Current Assets | 94.86M | 82.46M | 88.64M | 78.68M | 66.79M |
| Property, Plant & Equipment (Net) | 39.16M | 44.7M | 46.92M | 49.2M | 33.2M |
| Goodwill | 58.3M | 7.42M | 0 | 0 | 316K |
| Intangible Assets | 101.83M | 91.22M | 80.61M | 70M | 59.87M |
| Long-term Investments | 67.85M | 25.2M | 327K | 337K | 361K |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 1.18M | 2.93M | 2.16M | 11.79M | 1.63M |
| Total Non-current Assets | 268.31M | 171.47M | 130.01M | 131.32M | 95.37M |
| Total Assets | 363.17M | 253.93M | 218.65M | 210M | 162.17M |
| Account Payables | 3.13M | 3.62M | 3.3M | 2.21M | 2.89M |
| Short-term Debt | 145K | 0 | 3.49M | 3.06M | 3.14M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 247K | 182K | 543K | 140K | 534K |
| Other Current Liabilities | 44.73M | 8.29M | 3.41M | 3.85M | 5.16M |
| Total Current Liabilities | 52.75M | 25.07M | 15.52M | 13.97M | 16.89M |
| Long-term Debt | 3.8M | 3.48M | 0 | 0 | 0 |
| Deferred Tax Liabilities | 7.06M | 3.33M | 2.95M | 2.58M | 600K |
| Deferred Revenue (Non-current) | 415K | 398K | 0 | 0 | 17K |
| Other Non-current Liabilities | 6.05M | 4.57M | 612K | 695K | 1.16M |
| Total Non-current Liabilities | 18.27M | 12.18M | 7.61M | 6.91M | 5.54M |
| Total Liabilities | 71.02M | 37.25M | 23.13M | 20.88M | 22.43M |
| Common Stock | 149K | 158K | 165K | 181K | 198K |
| Retained Earnings | (146.21M) | (259.46M) | (320.23M) | (373.75M) | (448.77M) |
| Accumulated OCI | (607K) | (1.97M) | (305K) | (1K) | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 292.15M | 216.68M | 195.51M | 189.12M | 139.73M |
| Total Debt | 5.77M | 4.62M | 8.4M | 7.45M | 7.85M |
| Net Debt | (60.87M) | (33.84M) | (47.98M) | (31.86M) | (41.3M) |
Nano-X Imaging Ltd.
NASDAQ:NNOX
Intrinsic Alpha fair value
Locked
Current Price
$0.73
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.